KINIKSA PHARMACEUTICALS INTE (KNSA:NASDAQ)
$63.44 -1.94 (-2.9673%)
Analysed KINIKSA PHARMACEUTICALS INTE (KNSA:NASDAQ) News Sources
Biotech Kiniksa Pushes Toward A Buy Zone With Blockbuster Drug Sales In View
23-06-2026
yahoo.com
Here's Why You Should Add Kiniksa Stock to Your Portfolio Now
26-06-2026
yahoo.com
Grab These 4 Stocks With Solid Net Profit Margins to Maximize Returns
29-06-2026
yahoo.com
Kiniksa Pharmaceuticals International, plc (KNSA) Surges 5.4%: Is This an Indication of Further Gains?
30-06-2026
yahoo.com
What Makes Kiniksa Pharmaceuticals International, plc (KNSA) a Strong Momentum Stock: Buy Now?
30-06-2026
yahoo.com
Kiniksa Pharmaceuticals International, plc (KNSA) Is a Great Choice for 'Trend' Investors, Here's Why
06-07-2026
yahoo.com
Illumina, Inc. (ILMN) Hit a 52 Week High, Can the Run Continue?
08-07-2026
yahoo.com
AGIO's Filing for Mitapivat in SCD Gets FDA's Priority Tag, Stock Up
08-07-2026
yahoo.com
Axsome Begins Phase III Study on Solriamfetol for ADHD in Children
08-07-2026
yahoo.com
Kiniksa Pharmaceuticals International (KNSA) Joins Russell Indexes, Is The Upside Already Priced In?
09-07-2026
yahoo.com
What is the current price of KINIKSA PHARMACEUTICALS INTE (KNSA:NASDAQ)?
The current price of KINIKSA PHARMACEUTICALS INTE (KNSA:NASDAQ) is $63.44.
KINIKSA PHARMACEUTICALS INTE (KNSA:NASDAQ) absolute price change since previous trading day?
The absolute price change of KINIKSA PHARMACEUTICALS INTE (KNSA:NASDAQ) since the previous trading day is $-1.94.
KINIKSA PHARMACEUTICALS INTE (KNSA:NASDAQ) percentage price change since previous trading day?
The percentage price change of KINIKSA PHARMACEUTICALS INTE (KNSA:NASDAQ) since the previous trading day is -2.9673%.
What is the most recent average sentiment score for KINIKSA PHARMACEUTICALS INTE (KNSA:NASDAQ)?
The most recent average sentiment score for KINIKSA PHARMACEUTICALS INTE (KNSA:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for KINIKSA PHARMACEUTICALS INTE (KNSA:NASDAQ)?
The most recent sentiment for KINIKSA PHARMACEUTICALS INTE (KNSA:NASDAQ) is .
SEC-8K** Filing Available For KINIKSA PHARMACEUTICALS INTE (KNSA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.